Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy

Table 3

On-Treatment Adverse Events Reported in at Least 10% of Mipomersen Patients.

Table 3

doi: https://doi.org/10.1371/journal.pone.0049006.t003